This article presents 10 new medical diagnostic solutions advancing the field with the latest technologies and specialized applications. These companies introduce solutions like AI infertility trackers, spatial biology platforms, and liquid biopsy diagnostics offering non-invasive cancer detection. Each featured company drives significant progress in their respective domains, showcasing the diverse and expanding applications of advanced diagnostics in healthcare.
Continue reading to gain up-to-date and data-driven insights on:
Key Takeaways
Drawing insights from the Big Data & AI-powered StartUs Insights Discovery Platform that provides data on over 4.7+ million emerging companies globally, we explore the evolving landscape of the medical diagnostics industry. This sector is marked by key trends and a substantial workforce, shaping its future. This report was last updated 5 days ago. Spot an error or missing detail? Help us fix it by getting in touch! Here are some key insights at a glance:
- Latest Medical Diagnostics Trends: The current medical diagnostics trends include automation and robotics, point-of-care testing, next-generation sequencing, liquid biopsies, microfluidics, and lab-on-a-chip technologies.
- Medical Diagnostics Industry Statistics: The sector comprises 73K+ organizations worldwide. Out of these, 7K+ new medical and diagnostic companies were founded in the last five years, witnessing 2020 as the average founding year. On average, each of these companies employs about 16 people. Moreover, the average funding received by these 7K+ medical and diagnostic companies per round in the same span is USD 15.5 million.
- 10 New Medical Diagnostic Solutions to Watch:
- iCura Diagnostics – Spatial Multi-Omics Digital Pathology
- MetaSight Diagnostics – Liquid Biopsy Diagnostics
- PanGIA Biotech – Non-Invasive True Liquid Biopsy
- TrueMass – Charge Detection Mass Spectrometers
- Respire Diagnostics (REDI) – Exhaled Breath Condensate Biomarkers
- PreDoc.ai – Pre-Doctor Diagnostics Platform
- Yatiri Bio – Proteomics Data Analytics
- innovabiohealth – Digital Diagnostics Solution
- ImVitro – AI-powered Infertility Tracker
- AEQUIP Binomial Pathologist-Machine
Meet 10 out of 7K+ Emerging Medical Diagnostic Solutions
In this section, we highlight 10 emerging medical diagnostic solutions that are leading to innovative diagnostic solutions. These companies are rapidly responding to environmental concerns and evolving market demands. By pioneering AI-based digital pathology, liquid biopsy diagnostics, AI infertility tracker, and proteomics data analytics, these companies are setting new standards in the medical and diagnostic industry.
Note on Signal Strength
One of the unique metrics we feature for each company is Signal Strength, a proprietary data point generated by our Discovery Platform. It gauges the extent to which a company’s influence has permeated the global ecosystem of startups, scaleups, and emerging companies. This proprietary metric serves as a valuable guidepost for understanding a company’s standing in the broader market landscape.
1. iCura Diagnostics
- Founding Year: 2021
- Employee Range: 2-10
- Location: USA
- Signal Strength: Very Strong
- What they do: iCura Diagnostics leverages advanced laboratory technologies to provide diagnostic modules. The company’s services include spatial biology, liquid biopsy, proteomics, genomics, and biomarker discovery and validation tools. It covers specialties in anatomic pathology, clinical pathology, hematology, as well as clinical informatics, with a focused interest in digital pathology, histopathology, immuno-oncology, and oncology testing. Hospitals, research institutions, and pharmaceutical companies benefit from iCuraDx’s precise and rapid diagnostic capabilities.
2. MetaSight Diagnostics
- Founding Year: 2021
- Employee Range: 11-50
- Location: Israel
- Signal Strength: Very Strong
- What they do: Metasight Diagnostics enables precision oncology through advanced diagnostic technologies and a comprehensive analytical platform. The platform leverages multi-omics data to provide detailed molecular insights for personalized cancer treatment. The multi-omics data is generated through its proprietary metabolomics, lipidomics, and proteomics platform. Additionally, its comprehensive serum metabolomics dataset linked with electronic health records pursues additional omics. Oncologists, researchers, and healthcare institutions use these diagnostic tools to ensure data integrity and facilitate collaboration among medical professionals.
3. PanGIA Biotech
- Founding Year: 2023
- Employee Range: 11-50
- Location: USA
- Signal Strength: Medium
- What they do: PanGIA Biotech offers a urine-based, non-invasive bio-molecular profile testing solution. Its True Liquid Biopsy Platform combines machine learning algorithms with proprietary unbiased binding of small molecules, proteins, and cells, followed by a signal readout and final analysis. The solution helps in minimizing the patient’s discomfort and procedural risks. It allows serial monitoring of the disease progression and treatment responses, including cancers. Researchers, patients, and healthcare professionals benefit from the platform for personalized treatment development.
4. TrueMass
- Founding Year: 2020
- Employee Range: 2-10
- Location: UK
- Signal Strength: Very Strong
- What they do: TrueMass designs charge detection mass spectrometry (CDMS) instruments dedicated to macromolecule analysis. It combines traditional electrospray ionization (ESI) mass spectrometry with novel charge detection technology that enables the evaluation of a molecule’s true intact mass. This helps researchers achieve mass-to-charge ratio (m/z) resolution and charge of single ions. It facilitates high throughput analysis of large molecular weight biomolecules, and real-time deconvolution of transient signals for maximum spectral quality and good mass resolution.
5. Respire Diagnostics (REDI)
- Founding Year: 2020
- Employee Range: 2-10
- Location: UK
- Signal Strength: Very Strong
- What they do: REDI manufactures point-of-care devices that use the breath to identify biomarkers that correlate to diseases. REDI EBC Condenser collects exhaled breath condensate (EBC) samples for the detection of common respiratory diseases (COPD, asthma), sepsis, and physical fitness. It uses biomarkers like hydrogen peroxide (H2O2), lactate, and nitrites as a proxy for the identification of the disease. Fitness centers, healthcare providers, and sports professionals benefit significantly from these precise diagnostic tools.
6. PreDoc.ai
- Founding Year: 2021
- Employee Range: 2-10
- Location: India
- Signal Strength: Very Strong
- What they do: PreDoc.ai specializes in developing AI-powered diagnostic tools for precision medicine. The company employs advanced machine learning algorithms to analyze medical images, providing accurate and early disease detection. Its mobile application detects a child’s jaundice at home by analyzing the color of the child’s body and also enable COVID-19 screening by using cough sounds as a biomarker which is further analyzed by AI models to generate results. This solution is used by healthcare clinics, diagnostics centres and individuals for predictive diagnostics and enhanced patient care outcomes.
7. Yatiri Bio
- Founding Year: 2020
- Employee Range: 2-10
- Location: USA
- Signal Strength: Very Strong
- What they do: Yatiri Bio offers AI-enabled computational tools to explore human proteomics data. It provides two interactive data portals, ProteoBrowser and ProteoPathway that enable classical analyses such as differential expression, pathway enrichment, sample outlier tests, and metadata associations. It helps in understanding how and why particular drugs successfully eradicate disease. Its ProteoModels is a pre-clinical model backed by clinical proteome data that is used for optimized patient selection, rational exploration of combinational therapies, drug repurposing, identifying resistance mechanisms, and drug discovery with translatable biomarkers from the outset. It helps oncologists and healthcare professionals to better understand the mechanisms by which the drug functions and the patient subsets for whom these particular mechanisms will result in positive clinical outcomes.
8. innovabiohealth
- Founding Year: 2021
- Employee Range: 2-10
- Location: Italy
- Signal Strength: Strong
- What they do: Innovabiohealth innovates digital diagnostics and monitoring solutions. Its Testinclick service provides at-home lab tests. It sends self-collection kits for capillary blood, urine, or saliva at home, collects it, and generates reports online. It also provides an option to send a nurse at home for sample collection. It provides Niptest, a non-invasive prenatal diagnostics for chromosomal anomalies check, and Preclatest for the assessment of the risk of developing preeclampsia. It benefits patients, doctors, healthcare workers, facilities, and companies by enabling digitization in diagnostics.
9. ImVitro
- Founding Year: 2019
- Employee Range:11-50
- Location: France
- Signal Strength: Very Strong
- What they do: ImVitro leverages artificial intelligence to enhance in vitro fertilization (IVF) processes. Its platform, EMBRYOLY, utilizes AI-driven analysis to monitor and assess embryo development. EMBRYOLY integrates with existing lab equipment, providing real-time insights and predictive analytics to embryologists. This technology increases the accuracy of embryo transfer, improving IVF success rates. Additionally, EMBRYOLY ‘s interface simplifies complex data interpretation, aiding fertility specialists. Patients undergoing IVF treatments benefit from this approach with streamlined IVF procedures and better reproductive outcomes.
10. AEQUIP
- Founding Year: 2020
- Employee Range: 2-10
- Location: Italy
- Signal Strength: Medium Strong
- What they do: AEQUIP develops innovative biological AI-based staining solutions for research and diagnostic applications. Its product, Stains, utilizes advanced reagents to enhance cellular and tissue visualization. It offers precise and quanti-qualitative output, aiding in accurate microscopic analysis. Researchers and pathologists benefit from Stains by improving diagnostic accuracy and research outcomes. Stains include a range of stains tailored for specific cell types and tissue structures.
Quick Tip to Find New New Medical Diagnostic Solutions
Utilizing a SaaS platform like the Discovery Platform for identifying new medical diagnostic companies provides significant benefits compared to traditional scouting methods:
- Streamlined Efficiency: The Discovery Platform offers advanced tools that streamline the scouting process. It replaces hours of your conventional desk research, saving time and resources in identifying medical diagnostic innovations.
- Access to Real-time Insights: Gain a competitive edge with up-to-date information on the latest trends in the medical diagnostics industry. The platform keeps you informed with near real-time updates on emerging medical diagnostic solutions and news, enabling you to make swift and informed decisions.
- Tailored Exploration: Customize your search to focus on specific niches within the medical diagnostics sector, such as spatial biology, AI-driven infertility tracker, or liquid biopsy. The platform’s diverse filtering options allow you to target your scouting efforts precisely, ensuring that you find the most relevant and groundbreaking companies in the field.
Ready to Explore All New New Medical Diagnostic Solutions?
We’ve explored the dynamic landscape of the medical diagnostics industry, examining the latest trends and spotlighting exceptional companies driving innovation. To dive deeper, download our free Healthcare Report or schedule a demo of the Discovery Platform for a customized exploration of these groundbreaking developments. Interested in enhancing our coverage of startups and tech? We value insights from experts like you – reach out!
